M. Sealey

发表

OP-BRCM210084 1..17

Jacqueline A Palace, J. Kuhle, R. Hillenbrand, 2021 .

Distribution and efficacy of ofatumumab and ocrelizumab in humanized CD20 mice following subcutaneous or intravenous administration

B. Cornelissen, D. Anthony, D. Leppert, 2022, Frontiers in Immunology.

Metabolomics detects clinically silent neuroinflammatory lesions earlier than neurofilament-light chain in a focal multiple sclerosis animal model

Jacqueline A Palace, J. Kuhle, D. Anthony, 2022, Journal of Neuroinflammation.

Suppression of tau‐induced phenotypes by vitamin E demonstrates the dissociation of oxidative stress and phosphorylation in mechanisms of tau toxicity

C. Cowan, A. Mudher, M. Sealey, 2020, Journal of neurochemistry.

Distinct phenotypes of three-repeat and four-repeat human tau in a transgenic model of tauopathy

C. Cowan, A. Mudher, E. Skoulakis, 2017, Neurobiology of Disease.

Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms

F. Gleeson, N. Sibson, D. Anthony, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Age-related changes in tau and autophagy in human brain in the absence of neurodegeneration

M. Vargas-Caballero, C. Proud, D. Bulters, 2021, bioRxiv.

Low endogenous and chemical induced heat shock protein induction in a 0N3Rtau-expressing Drosophila larval model of Alzheimer's disease.

A. Mudher, A. Wyttenbach, S. Quraishe, 2013, Journal of Alzheimer's disease : JAD.

Microtubule stabilising peptides rescue tau phenotypes in-vivo

A. Mudher, S. Quraishe, M. Sealey, 2016, Scientific Reports.

Using Drosophila models of neurodegenerative diseases for drug discovery

A. Mudher, T. Newman, M. Sealey, 2011, Expert opinion on drug discovery.

Modelling Tauopathies in Drosophila: Insights from the Fruit Fly

C. Cowan, D. Allan, A. Mudher, 2011, International journal of Alzheimer's disease.

Microtubule stabilising peptides rescue tau phenotypes in-vivo

A. Mudher, S. Quraishe, M. Sealey, 2016, Scientific Reports.

Rescue from tau-induced neuronal dysfunction produces insoluble tau oligomers

C. Cowan, D. Allan, A. Mudher, 2015, Scientific Reports.

Tau-mediated axonal degeneration is prevented by activation of the WldS pathway

V. Perry, A. Mudher, T. Newman, 2020, bioRxiv.

Integrative biochemical, proteomics and metabolomics cerebrospinal fluid biomarkers predict clinical conversion to multiple sclerosis

Jacqueline A Palace, J. Kuhle, D. Anthony, 2021, Brain communications.

Classifying the antibody-negative NMO syndromes

Jacqueline Palace, D. Anthony, T. Claridge, 2019, Neurology: Neuroimmunology & Neuroinflammation.

Objective biomarkers for clinical relapse in multiple sclerosis: a metabolomics approach

E. Schiffer, Jacqueline A Palace, Luis E. Saldana, 2021, Brain communications.

A blood-based metabolomics test to distinguish relapsing–remitting and secondary progressive multiple sclerosis: addressing practical considerations for clinical application

Jacqueline Palace, Luis E. Saldana, D. Anthony, 2020, Scientific Reports.

Determination of CSF GFAP, CCN5, and vWF Levels Enhances the Diagnostic Accuracy of Clinically Defined MS From Non-MS Patients With CSF Oligoclonal Bands

Jacqueline A Palace, J. Kuhle, R. Hillenbrand, 2022, Frontiers in Immunology.